CINECA IRIS Institutional Research Information System

SABINI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.868
EU - Europa 858
AS - Asia 801
SA - Sud America 99
Continente sconosciuto - Info sul continente non disponibili 54
AF - Africa 52
OC - Oceania 3
Totale 3.735
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.827
SG - Singapore 301
SE - Svezia 260
CN - Cina 192
IT - Italia 169
DE - Germania 151
HK - Hong Kong 118
BR - Brasile 75
VN - Vietnam 59
BG - Bulgaria 57
GB - Regno Unito 57
FR - Francia 51
CA - Canada 30
IN - India 30
RU - Federazione Russa 27
AT - Austria 21
JP - Giappone 21
TR - Turchia 21
CI - Costa d'Avorio 18
FI - Finlandia 18
SN - Senegal 17
BD - Bangladesh 15
UA - Ucraina 11
VE - Venezuela 10
NL - Olanda 9
IQ - Iraq 8
PL - Polonia 8
MA - Marocco 7
PH - Filippine 7
BE - Belgio 5
PK - Pakistan 5
AR - Argentina 4
AZ - Azerbaigian 4
ID - Indonesia 4
SA - Arabia Saudita 4
AL - Albania 3
AU - Australia 3
ES - Italia 3
IE - Irlanda 3
KZ - Kazakistan 3
MX - Messico 3
ZA - Sudafrica 3
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
NP - Nepal 2
PA - Panama 2
UY - Uruguay 2
UZ - Uzbekistan 2
BB - Barbados 1
BH - Bahrain 1
DZ - Algeria 1
EC - Ecuador 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MZ - Mozambico 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
SV - El Salvador 1
TN - Tunisia 1
Totale 3.681
Salva come PNG Salva come JPEG
Città #
Ashburn 210
Woodbridge 152
Dallas 144
Fairfield 135
Singapore 116
Hong Kong 115
Houston 101
San Jose 97
Chandler 93
Santa Clara 92
Seattle 69
Sofia 57
Wilmington 49
Ann Arbor 47
New York 43
Los Angeles 40
Cambridge 37
Beijing 36
Shanghai 36
Munich 32
Serra 28
Boardman 27
Frankfurt am Main 26
Florence 23
London 22
Vienna 21
Ottawa 19
Princeton 19
Abidjan 18
Bremen 17
Dakar 17
Lawrence 17
Tokyo 17
Ho Chi Minh City 16
Medford 16
Rome 15
Lauterbourg 13
Milan 12
Pisa 12
Atlanta 11
Buffalo 11
Des Moines 11
Hanoi 11
Dearborn 10
Marseille 10
Dong Ket 9
Helsinki 8
Istanbul 8
Manchester 8
Warsaw 8
Chennai 7
Denver 7
Düsseldorf 7
Turku 7
Guangzhou 6
Izmir 6
Ogden 6
Orem 6
Brussels 5
Redondo Beach 5
San Diego 5
Tianjin 5
Toronto 5
Baghdad 4
Boulder 4
Brooklyn 4
Caracas 4
Changsha 4
Chicago 4
Columbus 4
Da Nang 4
Hercules 4
Lancaster 4
Montreal 4
Nanchang 4
Nanjing 4
Ossé 4
Phoenix 4
Poplar 4
Stockholm 4
São Paulo 4
Amsterdam 3
Aosta 3
Baku 3
Dhaka 3
Dublin 3
Fuzhou 3
Hebei 3
Jiaxing 3
Johannesburg 3
Lucca 3
Naples 3
Ningbo 3
Palermo 3
Paris 3
Pesqueira 3
Riyadh 3
San Francisco 3
Taiyuan 3
The Dalles 3
Totale 2.367
Salva come PNG Salva come JPEG
Nome #
Natural history of graves’ orbitopathy after treatment 281
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 253
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 245
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 244
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 229
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 221
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 220
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 191
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 190
Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato 189
Occurrence of Graves’ Orbitopathy and of Graves’ hyperthyroidism after a trauma to the eye 177
A case of drug-induced Graves’ Orbitopathy after combination therapy with Tremelimumab and Durvalumab 174
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 174
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 156
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 142
In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathy 136
Serum levels of rapamycin predict the response of Graves' orbitopathy to sirolimus 127
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 118
null 93
Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study 87
null 80
A large series of patients with anaplastic thyroid cancer managed in a tertiary referral center 8
Totale 3.735
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.759
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022327 0 3 2 44 87 31 3 9 40 35 4 69
2022/2023417 58 73 39 27 30 38 1 41 80 0 27 3
2023/2024139 8 5 19 2 18 28 10 9 0 3 23 14
2024/2025741 5 19 9 35 82 69 26 16 80 102 80 218
2025/20261.027 97 116 141 92 123 67 134 46 51 90 38 32
2026/2027146 146 0 0 0 0 0 0 0 0 0 0 0
Totale 3.735